INREBIC vs MYLERAN

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. INREBIC and MYLERAN are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	INREBIC	MYLERAN
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	FEDRATINIB HYDROCHLORIDE	BUSULFAN
Manufacturer	Bristol-Myers	Waylis Therap
Dosage forms	Capsule	Tablet
Drug class	—	Alkylating Drug
Boxed warning	None	Boxed warning
Treats	Primary Myelofibrosis	Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis

inrebic myleran

Rating

New

Pharmacy pays

—

Type

Active ingredient

FEDRATINIB HYDROCHLORIDE

BUSULFAN

Manufacturer

Bristol-Myers

Waylis Therap

Dosage forms

Capsule

Tablet

Drug class

—

Alkylating Drug

Boxed warning

None

Boxed warning

Treats

Primary Myelofibrosis

Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis

Frequently asked questions

What is the difference between Inrebic and Myleran?

Inrebic contains Fedratinib Hydrochloride, while Myleran contains Busulfan — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.